Page last updated: 2024-10-24

carbazilquinone and Lymphoma, Non-Hodgkin

carbazilquinone has been researched along with Lymphoma, Non-Hodgkin in 2 studies

Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takenaka, T1
Maruyama, K1
Kinoshita, T1
Sasako, M1
Sano, T1
Katai, H1
Matsuno, Y1
Sampi, K1
Masaoka, T1
Takagi, T1
Sakamoto, S1
Mikuni, C1
Kano, Y1

Trials

2 trials available for carbazilquinone and Lymphoma, Non-Hodgkin

ArticleYear
A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
    British journal of cancer, 1997, Volume: 76, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Che

1997
[Aclarubicin-combined combination chemotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:1

    Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Drug Resi

1989